JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY, cilt.11, sa.3, ss.207-211, 2015 (SCI-Expanded)
OBJECTIVE: Trastuzumab and lapatinib are widely used chemotherapeutic agents. Our aim in this study was to assess the possible ototoxicity of these chemotherapeutic agents.